Chueh, Chen-Han http://orcid.org/0000-0002-3337-2586
Tsai, Yi-Wen http://orcid.org/0000-0003-1422-7217
Chen, Zi-Rong http://orcid.org/0000-0002-4777-6792
Shiu, Ming-Neng http://orcid.org/0000-0003-1009-3696
Wen, Yu-Wen http://orcid.org/0000-0002-7979-3845
Chiang, Nai-Jung http://orcid.org/0000-0001-9292-0055
Article History
Accepted: 17 November 2022
First Online: 28 December 2022
Declarations
:
: This study received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
: Nai-Jung Chiang has received payment for lectures from Eli Lilly and Company, TTY Biopharm Company Limited, Ono Pharmaceutical Co., Ltd., Bristol Myers Squibb, PharmaEngine, Inc., and Roche. Chen-Han Chueh, Zi-Rong Chen, Ming-Neng Shiu, Yu-Wen Wen, and Yi-Wen Tsai have no conflicts of interest that are directly relevant to the content of this article.
: The Institutional Review Board of National Yang Ming Chiao Tung University, Taiwan approved this study (YM111012E).
: The data that support the findings of this study are available from the Ministry of Health and Welfare, Taiwan, but restrictions apply to the availability of these data, which were used under license for the current study and are not publicly available.
: The Institutional Review Board of National Yang Ming Chiao Tung University (IRB) agreed to waive the consent to participate for this research because this research is low risk. Furthermore, the possible risk to the research subjects is no more than that of those who did not participate in the research, and the exemption from obtaining prior consent does not affect the rights and interests of the research subjects.
: Consent to publish is not required because the IRB agreed that this research did not require consent to participate.
: The code supporting the findings of this study is available from the corresponding authors upon request.
: Conceptualization: Y-WW, Y-WT, N-JC; data curation: Z-RC; formal analysis: C-HC, Z-RC; methodology: M-NS, Y-WW, Y-WT; project administration: M-NS, Y-WT, N-JC; resources: Y-WT; software: C-HC, Z-RC; supervision: M-NS, Y-WW, Y-WT, N-JC; validation: C-HC; visualization: C-HC, Z-RC; writing, original draft: C-HC, Z-RC, Y-WT; writing, review and editing: C-HC, M-NS, Y-WW, Y-WT, N-JC. All authors read and approved the final manuscript.